Watch: a Stanford endocrinologist on GLP-1 weight-loss drugs Stanford Medicine endocrinologist Sun Kim, MD, walks through how GLP-1 medications actually work, who they are for, and what the clinical evidence says about long-term use
In a Phase 2 trial, adults with obesity lost about 24% of their body weight after 48 weeks, the largest drop reported for this class so far
If standard approaches do not work, extending the escalation timeline is preferable to microdosing
Formulation differences: do they change the risk
As a naturally occurring antioxidant, it's well-tolerated by most skin types and rarely causes severe adverse reactions
2 The Schilling test, which was once the diagnostic standard for pernicious anemia, is no longer available in the United States